Pinned
After 2 years of building in silence weβre so excited to finally share what weβve been working on at AminoChain and announce our $5M seed round led by @a16zcrypto !
AminoChain
200 posts
AminoChain
@Amino_Chain
Building Trust in Science and Healthcare | a16z CSX
Joined April 2023
- Biobanks are the backbone of biomedical research, but theyβre operating in silos. Researchers face major barriers in accessing bio-specimens: π Limited visibility across fragmented repositories β³ Slow, bureaucratic procurement processes π« Lack of transparency in consent &
- Desci has just hit the stratosphere ππweβre so back @a16zcrypto goes DeSci @bioprotocol genesis launching Sunday into a π @cz_binance out of jail @pumpdotscience +$2m vol on launch Q4 is going to be epic
- Super excited for @GolatoTyler and the announcement of @triplicate_xyz π pumped to have you on our cap table and to be a flagship investment π₯Thrilled to announce @triplicate_xyz - a new investment collective focused on the deinstitutionalization of science. Our goal is to support the future toolkit for scientific discovery from DeSci to AI. Join us and run your experiments in Triplicate. 𧡠triplicate.xyz
- Replying to @Amino_ChainAminoChain is building an L2 blockchain protocol that connects enterprise medical institutions, and on which user-owned decentralized healthcare applications can be built.
- Weβre very excited to share AminoChainβs acceptance into the @a16zcrypto CSX spring accelerator! See you all in London in a few weeks time π¬π§
- We're excited to announce that the @Amino_Chain Specimen Center beta version is now live! Biobanks and scientists from around the world have joined the completely open and transparent Specimen Center to search, license and distribute bio-samples for pre-clinical research. For
- Absolutely we are HIRING!! Please check out our open positions we canβt wait to hear from you β€οΈThis post is unavailable.
- Replying to @Amino_ChainThe first app built on AminoChain is a bio-sample marketplace that lets researchers query for and license samples across a network of biobanks. Patients can track their samples use, learn from new insights generated on their samples, and earn money back when these are sold.
- Imagine a world where biospecimen discovery is seamless, ethical, and transparent β where researchers can access high-quality samples in real-time, patients can track their contributions, and biorepositories can efficiently manage and share specimens without bottlenecks. Thatβs
- Replying to @Amino_ChainAminoChain is building an entirely new enterprise on-chain bioeconomy, where users will benefit from D-Apps in clinical recruitment, real world evidence, federated learning, and much more.
- Replying to @Amino_ChainTo learn more about AminoChain, our funding round, and opportunities to join our founding team, please see here.
